Improving Patients Lives Globally One Molecule At A Time
At Eirgen Pharma, we specialize in the development and manufacturing of high-quality high-potency and non high-potency Oral Solid Dose (OSD) products, including prescription drugs and generics for both human and companion animal health. As a leading CDMO, we provide comprehensive CDMO services spanning pharmaceutical development, manufacturing, and packaging solutions to ensure seamless market entry.
​
Based in Waterford, Ireland, our expert team is committed to delivering innovative, research-driven solutions with a focus on quality, safety, and efficiency. Partnering with global pharmaceutical leaders, we help bring life-changing therapies to market, improving patients lives worldwide.
Why Choose Eirgen Pharma?
INNOVATION
We take pride in fostering innovation, giving our Research & Development team the freedom and technology to meet your needs..
VERSATILITY
We offer flexibility, condensed timelines and cost savings, allowing the versatility required to meet your needs without compromising on quality.
OPERATIONAL EXCELLENCE
As a trusted partner to more than 120 pharmaceutical companies across 60 countries globally, we have developed unparalleled processes that accelerate your product's journey from concept to commercialization.
COMPLIANCE ASSURED
Our Ethics and Compliance program ensures you meet your project goals whilst adhering to global pharmaceutical and business regulations. We are approved by major regulatory authorities, including the EMA, HPRA, FDA, PMDA, and Health Canada.
Our Services
With over 20 years of industry-leading expertise, Eirgen Pharma is the CDMO of choice for high-potency drug development and manufacturing. From oncology treatments to antiviral and anti-inflammatory therapies for human and animal health, our state-of-the-art technologies and FDA-approved facilities ensure regulatory-compliant, high-quality pharmaceutical solutions that drive global healthcare forward.
